MedTrace Logo

Axillary Approach to Brachial Plexus Blockade Using Ketamine, Regional Versus Intravenous Administration

NCT05297422 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2022-03-28

No results posted yet for this study

Summary

The purpose of this study is to assess Ketamine as an adjuvant to Branchial Plexus Blockade.

Conditions

  • Branchial Plexus Blockade
  • Anesthesia

Interventions

PROCEDURE

Forearm surgey

Microsurgery Clinic , KAT Hospital Athens

DRUG

Ropivacaine

Ropivacaine

DRUG

Ketamine

Ketamine

Sponsors & Collaborators

  • National and Kapodistrian University of Athens

    lead OTHER

Principal Investigators

  • Theodoros Xanthos, Professor · National Kapodistrian University of Athens

Study Design

Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-20
Primary Completion
2023-05-31
Completion
2023-06-30

Countries

  • Greece

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05297422 on ClinicalTrials.gov